AGLE logo

Aeglea BioTherapeutics (AGLE) EV/EBITDA

EV/EBITDA

N/A

Mon, 01 Jan 0001 00:00:00 GMT


Summary


Performance

AGLE EV/EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

OtherAGLEvaluationmetrics:

EV/EBITDA Formula

EV/EBITDA =  
Enterprise Value
TTM EBITDA

AGLE EV/EBITDA Trends

PeriodPeriodEV/EBITDAEV/EBITDAEnterprise valueEnterprise valuePricePrice
6 m6 months---
1 y1 year---
5 y5 years---

AGLE EV/EBITDA Highs & Lows

PeriodPeriodHighHighCurrent vs highvs highLowLowCurrent vs lowvs low
1 m1-month
3 m3-month
6 m6-month
1 y1-year
3 y3-year2.34-3.22
5 y5-year2.34-5.97
alltimeall time2.34-9.84

Aeglea BioTherapeutics EV/EBITDA History

DateValue
2023
0.03(+200.0%)
2022
0.01(-100.3%)
2021
-3.50(-3.8%)
2020
-3.64(+40.0%)
DateValue
2019
-2.60(-25.9%)
2018
-3.51(+24.5%)
2017
-2.82(+475.5%)
2016
-0.49

FAQ

  • What is the all time high EV/EBITDA for Aeglea BioTherapeutics?

What is the all time high EV/EBITDA for Aeglea BioTherapeutics?

Aeglea BioTherapeutics all-time high EV/EBITDA is 2.34